期刊文献+

原发灶不明侵及皮肤的巨大颈部转移癌的手术及修复

Repair surgery for giant neck metastatic carcinoma of unknown primary focal neck skin invasion
原文传递
导出
摘要 目的探讨原发灶不明的侵及皮肤的巨大颈部转移癌的手术方法、手术技巧及修复方法。方法:原发灶不明的侵及皮肤的巨大颈部转移癌患者16例,行根治性颈淋巴结清扫术,术中切除足够的受侵皮肤,妥善解决暴露、止血、颈内静脉上下极的处理、颈动脉、迷走神经、颈交感神经干、膈神经及臂丛神经的保护等问题,应用肌皮瓣修复颈部巨大皮肤缺损,术后给予同期放化疗。结果:16例患者术中无颈动脉破裂大出血,2例因与颈总动脉粘连紧密分离时颈总动脉外膜破裂给予直接缝合修复血管;1例颈总动脉切除约1.5 cm,游离动脉后无张力给予端端吻合;1例术中证实颈内动脉已闭塞给予切除;2例切除部分迷走神经,1例行迷走神经端端吻合,1例胸长神经移植吻合;2例切除膈神经;16例均保留颈交感神经干及臂丛神经;16例颈部皮肤缺损均用胸大肌皮瓣修复。手术时间200~300min,术中失血量190~350ml。胸大肌皮瓣全部存活,无1例坏死。手术放化疗后随访3~50个月,死亡8例,死亡时间距离发病时间最长48个月。死于肺转移4例,骨转移2例,颈部复发1例,鼻咽大出血1例;其中3例发现原发灶,分别为鼻咽癌、扁桃体癌及食管癌。结论:原发灶不明的侵及皮肤的巨大颈部转移癌的手术是安全的,胸大肌皮瓣修复皮肤缺损疗效满意,不影响术后放化疗,可以提高局部控制率和患者的生存质量。 Objective:To explore the repair surgical methods,surgical skills and repair methods of the giant neck metastatic carcinoma of unknown primary focal neck skin invasion.Method:Radical lymphadenectomy were performed on 16 patients suffered from giant neck metastatic carcinoma of unknown primary focal neck skin invasion.The invasion skin was removed enough,the exposure,hemostatic,internal jugular vein of the upper and lower pole processing,carotid artery,vagus nerve,cervical sympathetic nerve,the phrenic nerve and brachial plexus nerve protection and other issues were all properly resolved.Neck skin giant defect was repaired with myocutaneous flap and concurrent chemoradiotherapy was carried out after surgery.Result:In 16 patients without carotid artery rupture,2cases due to adhesion and carotid artery closely separated carotid artery rupture with direct suture repair vessel;1cases of carotid resection of about 1.5cm,with anastomosis without tension;internal carotid artery occlusion confirmed was given resection in 1cases;2cases of partial vagus nerve resection;1cases of vagus nerve anastomosis,1cases of long thoracic nerve anastomosis;2cases of resection of phrenic nerve;16cases cervical sympathetic trunk and brachial plexus were preserved;16cases of neck skin defect were repaired with pectoralis major myocutaneous flap.The operative time 200-300 min,intraoperative blood loss 190-350 ml.Pectoralis major muscle flaps were all survival.All the patients were followed up for 3-50 months,8cases of death,the longest death time was 48 months from the disease,4cases died of lung metastasis,bone metastasis in2 cases,1cases of cervical recurrence,nasopharyngeal bleeding in 1cases;primary tonsil carcinoma,esophageal carcinoma and nasopharyngeal carcinoma were found in 3cases respectively.Conclusion:Repair surgery is safe for giant neck metastatic carcinoma of unknown primary focal neck skin invasion.Skin defect repair curative effect is satisfied repaired with pectoralis major myocutaneous flap which not only does not affect postoperative chemotherapy but also can improve the local control rate and life quality of patients.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2014年第18期1385-1389,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 颈部转移癌 原发灶不明 治疗 外科皮瓣 neck metastatic carcinoma unknown original focal treatment surgical flaps
  • 相关文献

参考文献14

  • 1PAVLIDIS N, FIZAZI K. Cancer of unknown prima- ry (CUP) [J]. Crit Rev Oncol Hematol, 2005, 54: 243-250.
  • 2DENNIS J L, HVIDSTEN T R, WIT E C, et al. Markers of adenocareinoma characteristic of the site of origin: development of a diagnostic algorithm[J]. Clin Cancer Res, 2005,11 : 3766- 3772.
  • 3KARAPOLAT I, KUMANLIOGLU K. Impact of FDG-PET/CT for the detection of unknown primary tumours in patients with cervical lymph node metasta- ses[J]. Mol Imaging Radionucl Ther, 2012,21:63- 68.
  • 4MEHTA V, JOHNSON P, TASSLER A, et al. A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery[J]. Laryngoscope,2013, 123:146-151.
  • 5KULAPADITHAROM B, BOONKITTICHAROEN V, KUNACHAK S. Fluorescence-guided biopsy in the diagnosis of an unknown primary cancer in pa- tients with metastatic cervical lymph nodes[J]. Ann Otol Rhinol Laryngol, 1999,108 : 700 - 704.
  • 6BISHOP J A, MAX J, WANG H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visual- ized by a novel E6/E7 mRNA in situ hybridization method[J]. Am J Surg Pathol, 2012,36 : 1874- 1882.
  • 7楼建林,郭良,赵坚强,王升晔.原发灶不明颈部淋巴结转移性鳞状细胞癌的治疗与预后分析[J].中华耳鼻咽喉头颈外科杂志,2013,48(1):32-36. 被引量:5
  • 8CIZMAREVIC B, LANISNIK B, DINEVSKI D. Cervical lymph node metastasis of squamous cell carci- noma from unknown primary tumor[J]. Coil Antro- pol,2012,36:27-32.
  • 9YAMADA T, OHTSUBO K, ISHIKAWA D,et al. Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective[J]. Gan To Kagaku Ryoho, 2012, 39:1291-1294.
  • 10CARPENTER S G, STONE W M, BOWER T C, et al. Surgical management of tumors invading the aorta and major arterial structures[J]. Ann Vasc Surg, 2011,25 : 1026 - 1035.

二级参考文献13

  • 1彭汉伟,曾宗渊,陈福进,崔念基,魏茂文,郭朱明,伍国号,张诠,杨安奎.不明原发灶颈部转移癌治疗失败原因和对策[J].中国肿瘤临床,2004,31(14):800-803. 被引量:5
  • 2刘明波,董淑华,唐平章.原发灶不明的颈部转移癌诊断和治疗[J].国外医学(耳鼻咽喉科学分册),2005,29(1):35-38. 被引量:11
  • 3王成锋,赵平.应重视不明原发灶肿瘤的临床研究[J].中华医学杂志,2006,86(26):1801-1803. 被引量:7
  • 4吴毅.原发灶不明颈部转移性鳞癌的诊治[J].中华肿瘤防治杂志,2006,13(12):881-883. 被引量:9
  • 5Pavlidis N, Pentheroudakis G, Plataniotis G. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. C|in Transl Oncol, 2009, 11 (6) :340-348.
  • 6Cerezo L, Raboso E, Ballesteros AI. Unknown primary cancer of the head and neck: a multidisciplinary approach. Clin Transl Oncol, 2011, 13(2) :88-97.
  • 7Patel RS, Clark J, Wyten R, et al. Squamous cell carcinoma from an unknown head and neck primary site: a "elective treatment" approach. Arch Otolaryngol Head Neck Surg, 2007, 133 (12): 1282-1287.
  • 8Shoushtari A, Saylor D, Kerr KL, et al. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys, 2011, 81(3) :e83-91.
  • 9Lu X, Hu C, Ji Q, et al. Squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: the impact of radiotherapy. Tumori, 2009, 95 (2) : 185-190.
  • 10Chen AMI "Farwell DG, Lau DH, et al. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio. Int J Radiat Oncol Biol Phys, 2011, 81 (2) : 346-352.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部